Synopsis
Synopsis
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Beta Alanylhistidine
2. Beta-alanylhistidine
3. Carnosine Hydrochloride
4. Carnosine, (d-his)-isomer
5. Hydrochloride, Carnosine
6. L Carnosine
7. L-carnosine
1. L-carnosine
2. 305-84-0
3. Beta-alanyl-l-histidine
4. Ignotine
5. Karnozin
6. Karnozzn
7. N-2-m
8. L-histidine, Beta-alanyl-
9. Polaprezinc
10. (3-aminopropanoyl)-l-histidine
11. (2s)-2-(3-aminopropanamido)-3-(1h-imidazol-4-yl)propanoic Acid
12. Chebi:15727
13. Nalpha-(beta-alanyl)-l-histidine
14. .beta.-alanyl-l-histidine
15. Nsc 524045
16. Brn 0087671
17. 8ho6pvn24w
18. L-histidine, N-beta-alanyl-
19. Beta-alanylhistidine
20. L-histidine, Beta-alanyl-, Homopolymer
21. Z 103
22. Z-103
23. N-beta-alanyl-l-histidine
24. L-ignotine
25. Mfcd00005207
26. (2~{s})-2-(3-azanylpropanoylamino)-3-(1~{h}-imidazol-4-yl)propanoic Acid
27. 1370422-07-3
28. Unii-8ho6pvn24w
29. L-histidine, N-.beta.-alanyl-
30. Sevitin
31. Betaala-his
32. B-alanylhistidine
33. Nsc-524045
34. Einecs 206-169-9
35. B-alanyl-l-histidine
36. Beta-alanyl-l-histidin
37. .beta.-alanylhistidine
38. Spectrum_001178
39. N-b-alanyl-l-histidine
40. Specplus_000374
41. Carnosine [mi]
42. Carnosine [inci]
43. Spectrum2_000454
44. Spectrum3_001212
45. Spectrum4_001673
46. Spectrum5_000605
47. Carnosine [vandf]
48. 3-aminopropionyl-histidine
49. Bmse000246
50. Bmse001002
51. C00386
52. Carnosine [who-dd]
53. N-(b-alanyl)-l-histidine
54. Schembl33769
55. Bspbio_002624
56. Kbiogr_002225
57. Kbioss_001658
58. 4-25-00-04381 (beilstein Handbook Reference)
59. Divk1c_006470
60. Spectrum1500944
61. N-(3-aminopropanoyl)histidine
62. Spbio_000528
63. Chembl242948
64. Gtpl4559
65. Kbio1_001414
66. Kbio2_001658
67. Kbio2_004226
68. Kbio2_006794
69. Kbio3_002124
70. Dtxsid80879594
71. L-carnosine, ~99%, Crystalline
72. (2s)-2-(3-aminopropanoylamino)-3-imidazol-4-ylpropanoic Acid
73. Tnp00340
74. Zinc2040854
75. N(alpha)-(beta-alanyl)-l-histidine
76. (2s)-2-(3-aminopropanoylamino)-3-(1h-imidazol-5-yl)propanoic Acid
77. Bdbm50485554
78. Ccg-38696
79. Stl466172
80. Akos010421481
81. Akos015963345
82. Cs-w014210
83. Db11695
84. Hy-w013494
85. Sdccgmls-0066726.p001
86. Ncgc00017390-01
87. Ncgc00017390-02
88. Ncgc00142487-01
89. Ac-17084
90. Ac-19690
91. Ac-31940
92. As-12570
93. A0222
94. L-carnosine, Vetec(tm) Reagent Grade, 98%
95. S5226
96. H11980
97. 305c840
98. Q413822
99. Sr-05000002473
100. Sr-05000002473-1
101. (2s)-2-(3-aminopropanamido)-3-(1h-imidazol-5-yl)propanoic Acid
102. (s)-2-(3-aminopropanamido)-3-(1h-imidazol-4-yl)propanoic Acid
103. (s)-2-(3-aminopropanamido)-3-(1h-imidazol-5-yl)propanoic Acid
104. 8v0
| Molecular Weight | 226.23 g/mol |
|---|---|
| Molecular Formula | C9H14N4O3 |
| XLogP3 | -4 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 6 |
| Exact Mass | 226.10659032 g/mol |
| Monoisotopic Mass | 226.10659032 g/mol |
| Topological Polar Surface Area | 121 Ų |
| Heavy Atom Count | 16 |
| Formal Charge | 0 |
| Complexity | 259 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Market Place
ANALYTICAL
Analytical Methods
ABOUT THIS PAGE
A L Carnosine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of L Carnosine, including repackagers and relabelers. The FDA regulates L Carnosine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. L Carnosine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of L Carnosine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A L Carnosine supplier is an individual or a company that provides L Carnosine active pharmaceutical ingredient (API) or L Carnosine finished formulations upon request. The L Carnosine suppliers may include L Carnosine API manufacturers, exporters, distributors and traders.
click here to find a list of L Carnosine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A L Carnosine DMF (Drug Master File) is a document detailing the whole manufacturing process of L Carnosine active pharmaceutical ingredient (API) in detail. Different forms of L Carnosine DMFs exist exist since differing nations have different regulations, such as L Carnosine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A L Carnosine DMF submitted to regulatory agencies in the US is known as a USDMF. L Carnosine USDMF includes data on L Carnosine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The L Carnosine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of L Carnosine suppliers with USDMF on PharmaCompass.
A L Carnosine CEP of the European Pharmacopoeia monograph is often referred to as a L Carnosine Certificate of Suitability (COS). The purpose of a L Carnosine CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of L Carnosine EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of L Carnosine to their clients by showing that a L Carnosine CEP has been issued for it. The manufacturer submits a L Carnosine CEP (COS) as part of the market authorization procedure, and it takes on the role of a L Carnosine CEP holder for the record. Additionally, the data presented in the L Carnosine CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the L Carnosine DMF.
A L Carnosine CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. L Carnosine CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of L Carnosine suppliers with CEP (COS) on PharmaCompass.
L Carnosine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of L Carnosine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right L Carnosine GMP manufacturer or L Carnosine GMP API supplier for your needs.
A L Carnosine CoA (Certificate of Analysis) is a formal document that attests to L Carnosine's compliance with L Carnosine specifications and serves as a tool for batch-level quality control.
L Carnosine CoA mostly includes findings from lab analyses of a specific batch. For each L Carnosine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
L Carnosine may be tested according to a variety of international standards, such as European Pharmacopoeia (L Carnosine EP), L Carnosine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (L Carnosine USP).
LOOKING FOR A SUPPLIER?
